Edwin M. Kania Jr., Director at ACCELERON PHARMA INC (XLRN), sold 1,000,000 shares at $35.89 ($32.0M) on 2014-04-22, disclosed to the SEC on 2014-04-24.
Scheduled sale ($32.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.89 | 6,936 | $249K | 0.8% |
| 2 | $35.89 | 114,746 | $4.1M | 12.9% |
| 3 | $33.81 | 1,351 | $46K | 0.1% |
| 4 | $33.81 | 22,349 | $756K | 2.4% |
| 5 | $31.45 | 48,713 | $1.5M | 4.8% |
| 6 | $31.45 | 805,905 |
| $25.3M |
| 79.1% |
| Total | $32.05 avg | 1,000,000 | $32.0M | 100% |
| Filing → |
| MRNA | SELL | 2019-12-11 | $3.8M | — | Filing → |
| TMDX | BUY | 2019-05-06 | $533K | — | Filing → |
| SELB | SELL | 2017-05-16 | $3.7M | — | Filing → |